secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2021-08-16T23:59:59+00:00
Accession:  0001801170-21-000020
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health CFO Joseph Wagner departs; Mark Herbers named interim CFO
-----------------------------------------------------------------------

- Joseph Wagner stepped down as CFO on August 13, 2021; will provide consulting services for 12 months at $10,000 per month.
- Mark Herbers (Director at AlixPartners) appointed interim CFO; company pays $175,000 per month to APS for his services.
- Herbers will serve as principal financial and accounting officer while permanent CFO search is conducted.
- Separation agreement extends post-termination exercise period of Wagner's vested stock options by one year.
- If consulting period is terminated early, company pays Wagner a lump sum equal to remaining monthly fees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/clov-20210813.htm
  HTML page:      https://secwatch.observer/filing/0001801170-21-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer